Interrelation between expression of adam 10 and mmp 9 and synthesis of peroxynitrite in doxorubicin induced cardiomyopathy

Biomolecules and Therapeutics

Volumn 21, Issue 5, 2013, Pages 371-380

  Lim, Sung Cil ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

ADAM; Cardiomyopathy; Doxorubicin; MMP

Indexed keywords

3 NITROTYROSINE; ADAM10 ENDOPEPTIDASE; COLLAGEN; DOXORUBICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; HEART LEFT VENTRICLE CONTRACTION; IMMUNOHISTOCHEMISTRY; M MODE ECHOCARDIOGRAPHY; MALE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; TOXICITY TESTING;

EID: 84887369399     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2013.034     Document Type: Article

References (31)

1. Arndt, M., Lendeckel, U., Rocken, C., Nepple, K., Wolke, C., Spiess, A., Huth, C., Ansorge, S., Klein, H. U. and Goette, A. (2002) Altered expression of ADAMs(A Disintegrin And Metalloproteinase) in fibrillating human atria. Circulation. 105, 720-725.
2. Ara, J., Prezedborski, S., Naaini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J. and Ischiropoulos, H. (1998) Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad Sci. U.S.A. 95, 7659-7663.
3. Beckman, J. S. and Koppenol, W. H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J. Physiol. 271, C1424-1437.
4. Black, R. A. and White, J. M. (1998) ADAMS: Focus on the protease domain. Current Opinion in Cell Biology 10, 654-659.
5. Cheung, P. Y., Sawicki, G., Wozniak, M., Wang, W., Radomski, M. W. and Schulz, R. (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101, 1833-1839.
6. Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V. and Weber, K.T. (1995) Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell Cardiol. 27, 1281-1292.
7. Coker, M. L., Doscher, M. A., Thomas, C. V., Galis, Z. S. and Spinale, F. G. (1999) Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am. J. Physiol. 277 (HeartCirc-Physiol. 46), H777-H787.
8. Dallas, D. J., Genever, P. G., Patton, A. J., Millichip, M. I., McKie, N., and Skerry, T. M. (1999) Localization of ADAM10 and Notch Re-ceptors in Bone. Bone 25, 9-15.
9. Dollery, C. M., McEwan, J. R., Henney, A. M. (1995) Matrix metalloproteinase and cardiovascular disease. Cir. Res. 77, 863-868.
10. Eiserich, J. P., Hristova, M., Cross, C. E., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B. and van der Vliet, A. (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391, 393-397.
11. Groves, J. T. (1999) Peroxynitrite: Reactive, invasive and enigmatic. Current Opinion in Chemical Biology. 3, 226-235.
12. Hunt, M. J., Aru, G. M., Hayden, M. R., Moore, C. K., Hoit, B. D. and Tyagi, S. C. (2002) Induction of oxidative stress and disintegrin metalloprotienase in human heart end-stage failure. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L239-L24. 2002.
13. Ischiropoulos, H. (1998) Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 356, 1-11.
14. Kalivendi, S. V., Kotamraju, S., Zhao, H., Jeseph, J. and Kalyanara-man, B. (2001) Doxorubicin-induced apotpoptosis is associated with increased transcription of endothelial nitric-oxide synthase. J. of Biological Chemistry 276, 47266-47276.
15. Kooy, N. W., Lewis, S. J., Royall, J. A., Ye, Y. Z., Kelly, D. R. and Beck-man, J. S. (1997) Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite. Crit. Care. Med. 25, 812-819.
16. Li, Y. Y., McTiernan, C. F. and Feldman, A. M. (1999) Proinflammatory cytokines regulate issue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardial cells. Cardiovasc. Res. 42, 162-172.
17. Lunn, C., Fan, X., Dalie, B., Miller, K., Zavodny, P., Narula, S. and Lundell, D. (1997) Purification of ADAM 10 from bovine spleen as a TNFaconvertase. FEBS. Lett. 400, 333-335.
18. Mann, D. L. and Spinale, F. G. (1998) Activation of matrix metallo-proteinases in the failing human heart: Breaking the tie that binds. Circulation 98, 1699-1702.
19. Millichip, M. I., Dallas, D. J., Wu, E., Dale, S. and Mckie, N. (1998) The Metallo-Disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochemical and Biophysical Communications 245, 594-598.
20. Okamoto, T., Akaike, T., Sawa, T., Miyamoto, Y. and van der Vliet, A. and Maeda, H. (2001) Activation of matrix metalloproteinase by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276, 29596-29602.
21. Pacher, P., Liaudet, L., Bai, P., Mabley, J. G., Kaminski, P. M., Birag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M. S., Groves, J. T. and Szabo C. (2003) Potent Metalloporphyrin peroxynitrite decomposition catalyst protects aginst the development of doxorubicin-induced cardiac dysfunction. Circulation 107, 896-904.
22. Pan, D. and Rubin, G. M. (1997) Kuzbanian controls proteolytic processing of notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271-280.
23. Radi, R., Beckman, J. S., Bush, K. M. and Freeman, B. A. (1991) Per-oxynitrite oxidation of sulfhydryls. J. Biol. Chem. 266, 4244-4250.
24. Singal, P. K. and Iliskovic, N. (1998) Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339, 900-905.
25. Siwik, D. A., Pagano, P. J. and Colucci, W. S. (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell. Physiol. 280, C53-C60.
26. Spinale, F. G. (2002) Matrix metalloproteinases: Regulation and dysregulation in the failing heart. Circ. Res. 90, 520-530.
27. Stetler-Stevenson, W. G. (1996) Dynamics of Matrix turnover during pathologic remodeling of the extracellular matrix. Am. J. Pathol. 148,1345-1350.
28. Sutton, M. G. and Sharpe, N. (2000) Left ventricular remodeling after myocardial infarction- pathology and therapy. Circulation 101, 2981-2988.
29. Thomas, C. V., Coker, M. L. and Zellner, J. L. (1998) Increased matrix metalloproteinase activity and selective upregulation in LV myocar-dium from patients with end-stage dilated cardiomyopathy. Circulation 97, 1708-1715.
30. Tyagi, S. C., Kumar, S. G., Banks, J. and Fortson, W. (1995) Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J. Mol. Cell. Cardiol. 27, 2177-2189.
31. Weinstein, D. M., Mihm, M. J. and Bauer, J. A. (2000) Cardiac per-oxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J. Pharmacol. Exp. Ther. 294, 396-401.